EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis

Woojin Back, Moonkyoung Jeong, Huyen-Thao Le, Ji-Ho Park iD

Advanced Healthcare Materials · 2025-07 · 14 (19)

DOI: 10.1002/adhm.202501613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.05.2025. Verfasst von Woojin Back und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio and Brain Engineering and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KA…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Hydrogels, Interleukin-4, Arthritis, Experimental. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent inflammation and progressive joint destruction. Current therapies primarily rely on general immune suppression, often leading to suboptimal outcomes and significant side effects. To address these challenges, an interleukin‐4 (IL‐4)‐tethered, hyaluronic acid‐based hydrogel is developed that withstands repeated mechanical stress in the joint space while fostering an immunomodulatory environment. The immunosuppressive hydrogel promotes anti‐inflammatory M2 macrophage polarization, creating an anti‐inflammatory microenvironment while preserving cartilage and mitigating joint damage. The mechanical properties of the hydrogel are carefully optimized for injectability and intra‐articular application. Its effectiveness is evaluated in a collagen‐induced arthritis (CIA) mouse model, demonstrating potential as a localized therapeutic approach. It is believed that this IL‐4‐tethered hydrogel platform will provide a foundation for the combinatorial treatment of RA and various inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidHydrogelsInterleukin-4Arthritis, ExperimentalImmunosuppressive AgentsAnimalsMiceMice, Inbred DBAMacrophagesHyaluronic AcidHumans

Stichwörter der Autor:innen

cytokinehydrogelimmunomodulationlocalized therapyrheumatoid arthritis

Substanzen

HydrogelsInterleukin-4Immunosuppressive AgentsHyaluronic Acid

Autor:innen und Institutionen

  • Department of Bio and Brain Engineering and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.

ORCID-Profile: Ji-Ho Park

Förderung

  • National Research Foundation

Zitieren

APA

Back, W., Jeong, M., Le, H. T., & Park, J. H. (2025). Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis. Advanced Healthcare Materials, 14(19). https://doi.org/10.1002/adhm.202501613

Vancouver

Back W, Jeong M, Le HT, Park JH. Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis. Advanced Healthcare Materials. 2025;14(19). doi:10.1002/adhm.202501613

BibTeX
@article{Back2025,
  author = {Back, Woojin and Jeong, Moonkyoung and Le, Huyen-Thao and Park, Ji-Ho},
  title = {Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {19},
  doi = {10.1002/adhm.202501613}
}
Kostenlos starten →